Etybenzatropine
 | |
| Clinical data | |
|---|---|
| Routes of administration | Oral, IM, IV |
| ATC code | N04AC30 (WHO) |
| Identifiers | |
| |
| CAS Number | 524-83-4 |
| PubChem (CID) | 71637 |
| ChemSpider |
16736129  Y |
| UNII |
G1X2X9N95N Y |
| KEGG |
D04087 Y |
| Chemical and physical data | |
| Formula | C22H27NO |
| Molar mass | 321.456 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
| (verify) | |
Etybenzatropine (INN), also known as ethybenztropine (USAN, BAN) and tropethydrylin, is an anticholinergic/antihistamine marketed under the trade names Panolid, Ponalid, and Ponalide, which is used as an antiparkinsonian agent. Like its analogue benzatropine, it may act as a dopamine reuptake inhibitor.
See also
References
| Dopaminergics |
| ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anticholinergics | |||||||||||||||||||
| Others | |||||||||||||||||||
| |||||||||||||||||||
| D1-like |
| ||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D2-like |
| ||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| Receptor (ligands) |
| ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Transporter (inhibitors) |
| ||||||||||||||
| Enzyme (inhibitors) |
| ||||||||||||||
| Others |
| ||||||||||||||
This article is issued from Wikipedia - version of the 9/27/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.